A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
Discover how the ALYREF biomarker predicts bladder cancer aggressiveness and boosts immunotherapy response. Find out more ...
Bladder cancer ranks among the ten most common types of cancer worldwide. The main treatment is bladder removal surgery, and despite advances in systemic therapies, recurrence is frequent in the most ...
Bladder cancer ranks among the ten most common types of cancer worldwide. The main treatment is bladder removal surgery, and ...
The FDA recently approved a pretzel-shaped implant that helps some bladder cancer patients keep their bladder. Dr. Chris ...
Bladder cancer is often treated by removing visible tumors and using a type of immunotherapy called BCG, delivered through a ...
Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.
Stage 2 vaginal cancer involves spread beyond the vaginal wall but not to the pelvic sidewall, with symptoms like abnormal ...
The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results